Core Viewpoint - Shenzhen Yuntian Lifei Technology Co., Ltd. is a leading AI company in China, focusing on the research, design, and commercialization of AI inference chips, with a complete closed-loop from infrastructure to product development and commercialization [1] Company Overview - Yuntian Lifei is ranked among the top three providers of AI inference chip-related products and services in China based on revenue projections for 2024 [1] - The company is also ranked among the top two providers specifically for NPU-driven AI inference chips in the same market [1] Product and Technology - The company's IFIC foundation enables algorithm chip capabilities, allowing for optimized chip design through a deep understanding of application scenarios and algorithm development [2] - Key products include the NPU product Nova, AI inference chips such as DeepEye and DeepEdge, and supporting tools like Hy3CAN and IFIE software platform [2] - The IFMind large model is capable of visual, text, and language analysis, supported by the Hy3CAN hardware enabling tool and IFIE software development suite [2] Industry Growth - The AI inference chip market in China is experiencing rapid growth, with market size projected to increase from 11.3 billion RMB in 2020 to 162.6 billion RMB in 2024, reflecting a compound annual growth rate (CAGR) of 94.9% [3] - The market is expected to continue growing at a CAGR of 53.4% from 2024 to 2029, reaching 1,383 billion RMB by 2029 [3] - There is increasing demand for high-performance inference computing from cloud service providers, AI companies, telecom operators, and electronic manufacturers [3] Financial Performance - For the fiscal years 2022, 2023, and projected for 2024, the company reported revenues of approximately 546 million RMB, 506 million RMB, and 917 million RMB respectively [4] - The company incurred losses of approximately 448 million RMB, 384 million RMB, and 572 million RMB for the same periods [4]

Core Viewpoint - Shenzhen Yuntian Lifei Technology Co., Ltd. (Yuntian Lifei) is preparing for an IPO on the Hong Kong Stock Exchange, with a focus on AI inference chips and related products and services, positioning itself as a leading player in the Chinese AI market [1][4]. Company Overview - Yuntian Lifei is recognized as a leading AI company in China, specializing in the research, design, and commercialization of AI inference chips. The company integrates a deep understanding of AI algorithms and practical applications into its high-performance, cost-effective products [4]. - The company ranks among the top three providers of AI inference chip-related products and services in China, based on revenue projections for 2024 [4]. Product and Technology - The company's IFIC foundation enables algorithm chip integration, allowing for optimized chip designs that efficiently support multiple application scenarios. Key products include the NPU product Nova, AI inference chips (DeepEye, DeepEdge, and in-development products DeepVerse and DeepXBot), and the Hy3CAN hardware enabling tool and IFIE software platform [5]. - Yuntian Lifei's Nova product offers scalable AI inference capabilities applicable across edge and cloud environments, while the Hy3CAN tool provides a unified programming interface for chip capabilities [5]. Market Growth - The AI inference chip market in China is experiencing rapid growth, with market size projected to increase from 11.3 billion RMB in 2020 to 162.6 billion RMB by 2024, reflecting a compound annual growth rate (CAGR) of 94.9%. The market is expected to continue growing at a CAGR of 53.4% from 2024 to 2029, reaching 1.383 trillion RMB by 2029 [6]. Financial Performance - For the fiscal years 2022, 2023, and projected figures for 2024, Yuntian Lifei reported revenues of approximately 546.2 million RMB, 506.0 million RMB, and 917.4 million RMB, respectively. The company incurred losses of about 447.7 million RMB, 384.1 million RMB, and 572.2 million RMB during the same periods [7][8].

Core Viewpoint - Shenzhen Yuntian Lifei Technology Co., Ltd. (Yuntian Lifei) is a leading AI company in China, focusing on the research, design, and commercialization of AI inference chips, and is preparing for an IPO with joint sponsors including Huatai International, CITIC Securities, and CMB International [1][5]. Company Overview - Yuntian Lifei specializes in AI inference chips, integrating deep understanding of AI algorithms and practical applications to create high-performance, cost-effective products for enterprise, consumer, and industry-level applications [5]. - The company is ranked among the top three providers of AI inference chip-related products and services in China, based on projected revenue for 2024 [5]. Product and Technology - The company's IFIC foundation enables algorithm chip integration, allowing for optimized chip designs that efficiently support multiple application scenarios [6]. - Key products include the NPU product Nova, AI inference chips (DeepEye, DeepEdge, and in-development products DeepVerse and DeepXBot), and supporting tools like Hy3CAN and IFIE software platform [6]. Market Growth - The AI inference chip market in China is experiencing rapid growth, with market size projected to increase from RMB 11.3 billion in 2020 to RMB 162.6 billion by 2024, representing a compound annual growth rate (CAGR) of 94.9% [7]. - The market is expected to continue growing at a CAGR of 53.4% from 2024 to 2029, reaching RMB 1,383 billion by 2029 [7]. Financial Performance - In the fiscal years 2022, 2023, and projected for 2024, Yuntian Lifei reported revenues of approximately RMB 546 million, RMB 506 million, and RMB 917 million, respectively [8]. - The company incurred losses of approximately RMB 448 million, RMB 384 million, and RMB 572 million for the same periods [8].

Core Viewpoint - Yuntian Lifei is a leading AI company in China, focusing on the research, design, and commercialization of AI inference chips, aiming to create a complete closed loop from infrastructure to product design and commercialization [4]. Industry Overview - The AI inference chip market in China is experiencing rapid growth, with the market size projected to increase from RMB 11.3 billion in 2020 to RMB 162.6 billion by 2024, representing a compound annual growth rate (CAGR) of 94.9%. It is expected to reach RMB 1,383 billion by 2029, with a CAGR of 53.4% from 2024 to 2029 [4]. Company Positioning - Yuntian Lifei ranks among the top three providers of AI inference chip products and services in China, and is also positioned as one of the top two providers specifically for NPU-driven AI inference chips based on projected revenue for 2024 [4]. Product Development - The company has developed the IFIC platform, which enables algorithm chip capabilities, and has created several NPU products, including Nova, DeepEye, DeepEdge, and others, along with supporting hardware and software tools [5]. Financial Performance - For the fiscal years ending March 31, 2022, 2023, 2024, and the first quarter of 2025, Yuntian Lifei reported revenues of approximately RMB 546.2 million, RMB 506.0 million, RMB 917.4 million, and RMB 264.0 million, respectively. The gross profits for the same periods were approximately RMB 174.1 million, RMB 119.0 million, RMB 192.1 million, and RMB 76.0 million [6][7].